Variant report

Variant	nsv460135
Chromosome Location	chr2:234242347-234288048
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:1040)
CpG islands
(count:917)
Chromatin interactive
region (count:62)
LncRNA
region (count:3)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:1040 , 50 per page) page: 1 2 3 4 5 6 7 ... 21

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr2:234269125-234269671	K562	blood:	n/a	n/a
2	ARID3A	chr2:234259317-234260227	K562	blood:	n/a	n/a
3	ARID3A	chr2:234253215-234253281	HepG2	liver:	n/a	n/a
4	ATF1	chr2:234259293-234259702	K562	blood:	n/a	n/a
5	ATF2	chr2:234272299-234272984	GM12878	blood:	n/a	n/a
6	ATF2	chr2:234262604-234263118	GM12878	blood:	n/a	n/a
7	ATF3	chr2:234259432-234259707	K562	blood:	n/a	n/a
8	ATF3	chr2:234259348-234259772	K562	blood:	n/a	n/a
9	BACH1	chr2:234263723-234263984	H1-hESC	embryonic stem cell:	n/a	n/a
10	BCL3	chr2:234259246-234260008	A549	lung:	n/a	chr2:234259570-234259579
11	BCL3	chr2:234263832-234264395	A549	lung:	n/a	n/a
12	BCL3	chr2:234258905-234259767	A549	lung:	n/a	chr2:234259570-234259579
13	BCL3	chr2:234247428-234247832	GM12878	blood:	n/a	chr2:234247800-234247809
14	BCL3	chr2:234247534-234247800	GM12878	blood:	n/a	n/a
15	BCLAF1	chr2:234266970-234267551	GM12878	blood:	n/a	n/a
16	BCLAF1	chr2:234272334-234272873	GM12878	blood:	n/a	n/a
17	BCLAF1	chr2:234284534-234285055	GM12878	blood:	n/a	n/a
18	BCLAF1	chr2:234262238-234262967	GM12878	blood:	n/a	n/a
19	BHLHE40	chr2:234259271-234259722	K562	blood:	n/a	n/a
20	BHLHE40	chr2:234242708-234242953	K562	blood:	n/a	n/a
21	BHLHE40	chr2:234281609-234281863	K562	blood:	n/a	n/a
22	BHLHE40	chr2:234251886-234252089	K562	blood:	n/a	n/a
23	BHLHE40	chr2:234260043-234260428	K562	blood:	n/a	n/a
24	BHLHE40	chr2:234245462-234245472	HepG2	liver:	n/a	n/a
25	BHLHE40	chr2:234246726-234247173	K562	blood:	n/a	n/a
26	BHLHE40	chr2:234262241-234262644	K562	blood:	n/a	n/a
27	BHLHE40	chr2:234263584-234263970	GM12878	blood:	n/a	chr2:234263690-234263706 chr2:234263683-234263699
28	CBX3	chr2:234249935-234250238	K562	blood:	n/a	n/a
29	CBX3	chr2:234259111-234259942	HCT-116	colon:	n/a	n/a
30	CBX3	chr2:234259093-234259892	HCT-116	colon:	n/a	n/a
31	CBX3	chr2:234259280-234259774	K562	blood:	n/a	n/a
32	CCNT2	chr2:234263138-234263393	K562	blood:	n/a	n/a
33	CCNT2	chr2:234269362-234269721	K562	blood:	n/a	n/a
34	CCNT2	chr2:234262308-234262911	K562	blood:	n/a	chr2:234262453-234262473
35	CEBPB	chr2:234248065-234248489	Hela-S3	cervix:	n/a	chr2:234248278-234248289
36	CEBPB	chr2:234265550-234265861	HepG2	liver:	n/a	n/a
37	CEBPB	chr2:234265594-234265744	K562	blood:	n/a	n/a
38	CEBPB	chr2:234251967-234252352	K562	blood:	n/a	chr2:234252160-234252171
39	CEBPB	chr2:234248109-234248455	HepG2	liver:	n/a	chr2:234248278-234248289
40	CEBPB	chr2:234252080-234252295	Hela-S3	cervix:	n/a	chr2:234252160-234252171
41	CEBPB	chr2:234278645-234278752	K562	blood:	n/a	n/a
42	CEBPB	chr2:234259275-234259791	Hela-S3	cervix:	n/a	n/a
43	CEBPB	chr2:234280226-234280235	H1-hESC	embryonic stem cell:	n/a	n/a
44	CEBPB	chr2:234278580-234278809	A549	lung:	n/a	n/a
45	CEBPB	chr2:234251988-234252353	HepG2	liver:	n/a	chr2:234252160-234252171
46	CEBPB	chr2:234248139-234248400	MCF-7	breast:	n/a	chr2:234248278-234248289
47	CEBPB	chr2:234248169-234248370	K562	blood:	n/a	chr2:234248278-234248289
48	CEBPB	chr2:234278545-234278864	IMR90	lung:	n/a	n/a
49	CEBPB	chr2:234248142-234248419	K562	blood:	n/a	chr2:234248278-234248289
50	CEBPB	chr2:234252055-234252244	K562	blood:	n/a	chr2:234252160-234252171

(count:917 , 50 per page) page: 1 2 3 4 5 6 7 ... 19

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr2:234263768-234263818	GM12892	blood:	n/a
2	chr2:234262964-234263014	HPAEpiC	pulmonary alveolar:	n/a
3	chr2:234263768-234263818	GM12892	blood:	n/a
4	chr2:234262964-234263014	HPAEpiC	pulmonary alveolar:	n/a
5	chr2:234261386-234261436	AG09319	gingival:	n/a
6	chr2:234261725-234261775	A549	lung:	n/a
7	chr2:234263251-234263301	LNCaP	prostate:	n/a
8	chr2:234262784-234262834	PFSK-1	brain:	n/a
9	chr2:234262710-234262760	MCF-7	breast:	n/a
10	chr2:234262710-234262760	NH-A	brain:	n/a
11	chr2:234281690-234281740	SKMC	muscle:	n/a
12	chr2:234262964-234263014	NHDF-neo	bronchial:	n/a
13	chr2:234262964-234263014	ProgFib	skin:	n/a
14	chr2:234262952-234263002	SK-N-MC	brain:	n/a
15	chr2:234262348-234262398	Jurkat	blood:	n/a
16	chr2:234281690-234281740	PFSK-1	brain:	n/a
17	chr2:234281690-234281740	HUVEC	blood vessel:	n/a
18	chr2:234261155-234261205	CMK	blood:	n/a
19	chr2:234262348-234262398	SK-N-SH	brain:	n/a
20	chr2:234262348-234262398	IMR90	lung:	fetal
21	chr2:234261155-234261205	HRCEpiC	kidney:	n/a
22	chr2:234262964-234263014	NB4	blood:	n/a
23	chr2:234261386-234261436	HRPEpiC	eye:	n/a
24	chr2:234262952-234263002	AoSMC	blood vessel:	n/a
25	chr2:234261386-234261436	HAEpiC	amniotic membrane:	n/a
26	chr2:234261155-234261205	NHDF-neo	bronchial:	n/a
27	chr2:234263251-234263301	NB4	blood:	n/a
28	chr2:234262952-234263002	HCPEpiC	choroid plexus:	n/a
29	chr2:234264163-234264213	GM12878	blood:	n/a
30	chr2:234261155-234261205	RPTEC	kidney:	n/a
31	chr2:234260986-234261036	AG04449	skin:	fetal
32	chr2:234262978-234263028	GM12891	blood:	n/a
33	chr2:234262952-234263002	HIPEpiC	eye:	n/a
34	chr2:234255578-234255628	ovcar-3	ovarian:	n/a
35	chr2:234263768-234263818	H1-hESC	embryonic stem cell:	embryo
36	chr2:234281690-234281740	SAEC	small airway:	n/a
37	chr2:234261386-234261436	HUVEC	blood vessel:	n/a
38	chr2:234262964-234263014	AG09309	skin:	n/a
39	chr2:234264163-234264213	Hela-S3	cervix:	n/a
40	chr2:234261386-234261436	HPAEpiC	pulmonary alveolar:	n/a
41	chr2:234281690-234281740	K562	blood:	n/a
42	chr2:234281690-234281740	NHDF-neo	bronchial:	n/a
43	chr2:234281690-234281740	H1-hESC	embryonic stem cell:	embryo
44	chr2:234264163-234264213	HRCEpiC	kidney:	n/a
45	chr2:234262784-234262834	GM19239	blood:	n/a
46	chr2:234260986-234261036	SK-N-MC	brain:	n/a
47	chr2:234262978-234263028	Jurkat	blood:	n/a
48	chr2:234263251-234263301	AG04449	skin:	fetal
49	chr2:234261386-234261436	BE2_C	brain:	n/a
50	chr2:234255578-234255628	AG09309	skin:	n/a

(count:62 , 50 per page) page: 1 2

No.	Distal block	Cell Line	Cell type
1	chr2:234159356..234161467-chr2:234246206..234249085,2	MCF-7	breast:
2	chr2:234268370..234271301-chr2:234272782..234274446,2	K562	blood:
3	chr2:234276899..234278989-chr2:234282956..234285583,2	K562	blood:
4	chr2:234159288..234161886-chr2:234264094..234265602,2	MCF-7	breast:
5	chr2:234266865..234268565-chr2:234269887..234272310,2	K562	blood:
6	chr2:234252596..234255070-chr2:234259544..234261790,2	MCF-7	breast:
7	chr2:234243954..234247958-chr2:234256896..234259564,3	MCF-7	breast:
8	chr2:234262927..234266874-chr2:234267273..234270022,5	MCF-7	breast:
9	chr2:234216148..234218067-chr2:234242398..234244264,2	MCF-7	breast:
10	chr2:234238246..234240780-chr2:234263095..234264681,2	K562	blood:
11	chr2:234260930..234263276-chr20:55839671..55841991,2	MCF-7	breast:
12	chr2:234263725..234265766-chr2:234287688..234290576,3	MCF-7	breast:
13	chr2:234245499..234247293-chr2:234261946..234264130,2	K562	blood:
14	chr2:234163205..234166188-chr2:234263952..234265730,2	MCF-7	breast:
15	chr2:234264479..234266031-chr2:234270714..234272402,2	K562	blood:
16	chr2:234242282..234244298-chr2:234262922..234265541,2	MCF-7	breast:
17	chr2:234264479..234266031-chr2:234270714..234272402,2	K562	blood:
18	chr2:234264990..234266555-chr2:234275771..234278254,2	K562	blood:
19	chr2:234265828..234267966-chr2:234273023..234275764,2	K562	blood:
20	chr2:234264990..234266555-chr2:234275771..234278254,2	K562	blood:
21	chr2:234262735..234265593-chr2:234266002..234267611,2	K562	blood:
22	chr2:234276899..234278989-chr2:234282956..234285583,2	K562	blood:
23	chr2:234268370..234271301-chr2:234272782..234274446,2	K562	blood:
24	chr2:234244512..234246230-chr2:234262489..234264948,2	MCF-7	breast:
25	chr2:234223100..234224098-chr2:234259138..234259923,2	MCF-7	breast:
26	chr2:234282165..234285596-chr2:234285963..234289154,3	MCF-7	breast:
27	chr2:234242293..234245038-chr2:234245423..234247780,3	MCF-7	breast:
28	chr2:234247812..234248755-chr2:234257486..234258176,3	MCF-7	breast:
29	chr2:234160002..234161727-chr2:234263204..234265213,2	MCF-7	breast:
30	chr2:234243950..234246353-chr2:234247665..234249180,2	K562	blood:
31	chr2:234198551..234200102-chr2:234262598..234264638,2	MCF-7	breast:
32	chr2:234242282..234244298-chr2:234262922..234265541,2	MCF-7	breast:
33	chr2:234266865..234268565-chr2:234269887..234272310,2	K562	blood:
34	chr2:234261499..234266840-chr2:234267799..234272402,9	K562	blood:
35	chr2:234262086..234263728-chr2:234268107..234269688,2	MCF-7	breast:
36	chr2:234260877..234265191-chr2:234275776..234278717,4	K562	blood:
37	chr2:234242293..234245038-chr2:234245423..234247780,3	MCF-7	breast:
38	chr2:234195095..234197515-chr2:234263227..234265841,2	MCF-7	breast:
39	chr2:234236421..234239312-chr2:234248555..234251486,2	K562	blood:
40	chr2:234247812..234248755-chr2:234257486..234258176,3	MCF-7	breast:
41	chr2:234238740..234240381-chr2:234244254..234246759,2	MCF-7	breast:
42	chr2:234259457..234261123-chr2:234261520..234263458,2	MCF-7	breast:
43	chr2:234259434..234265610-chr2:234290886..234296562,9	MCF-7	breast:
44	chr2:234268370..234271611-chr2:234272538..234274981,4	K562	blood:
45	chr2:234268370..234271611-chr2:234272538..234274981,4	K562	blood:
46	chr2:234253774..234256883-chr2:234262038..234267744,5	K562	blood:
47	chr2:234263404..234265699-chr2:234319043..234321996,3	MCF-7	breast:
48	chr2:233749631..233751772-chr2:234261254..234263295,2	MCF-7	breast:
49	chr2:234258654..234260896-chr2:234262665..234264444,3	MCF-7	breast:
50	chr2:234257933..234260937-chr2:234261415..234264229,3	K562	blood:

(count:3 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-USP40-1	chr2:234259778-234260434	NONHSAT077479
2	lnc-USP40-1	chr2:234260441-234262062	NONHSAT077479
3	lnc-USP40-1	chr2:234259778-234262062	ENSG00000259793.1

No data

Variant related genes	Relation type
SAG	TF binding region
DGKD	TF binding region
ENSG00000259793	TF binding region
ENSG00000243637	TF binding region
SAG	CpG island
DGKD	CpG island
ENSG00000259793	CpG island
ENSG00000243637	CpG island
ENSG00000259793	chromatin interactions
ENSG00000243637	chromatin interactions
ENSG00000077044	chromatin interactions
ENSG00000101144	chromatin interactions
ENSG00000201013	chromatin interactions
ENSG00000130561	chromatin interactions
ENSG00000066248	chromatin interactions
ENSG00000085978	chromatin interactions
ENSG00000226308	chromatin interactions
ENSG00000251791	chromatin interactions

Extended variants
information (count: 1829 )
Associated
traits (count: 61 )

Variant overlapped rSNPs/rCNVs (count:1829 , 50 per page) page: 1 2 3 4 5 6 7 ... 37

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs1000141	chr2:234242347-234242348	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs143719194	chr2:234242391-234242392	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
3	rs191190235	chr2:234242410-234242411	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
4	rs540599932	chr2:234242422-234242423	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
5	rs560297409	chr2:234242442-234242443	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
6	rs527781199	chr2:234242443-234242444	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
7	rs182831853	chr2:234242505-234242506	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
8	rs544700400	chr2:234242655-234242656	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
9	rs187602396	chr2:234242664-234242665	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
10	rs148082983	chr2:234242716-234242717	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
11	rs547570603	chr2:234242732-234242733	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
12	rs202064204	chr2:234242744-234242745	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
13	rs192830785	chr2:234242787-234242788	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
14	rs544158609	chr2:234242837-234242838	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
15	rs372676555	chr2:234242839-234242840	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
16	rs141863999	chr2:234242849-234242850	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
17	rs115861948	chr2:234242850-234242851	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
18	rs78191154	chr2:234242884-234242885	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
19	rs532302329	chr2:234242912-234242913	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
20	rs552413403	chr2:234242946-234242947	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
21	rs140161105	chr2:234242959-234242960	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
22	rs569988575	chr2:234242961-234242962	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
23	rs34197333	chr2:234242991-234242992	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
24	rs553996167	chr2:234242995-234242996	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
25	rs554927690	chr2:234243018-234243019	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
26	rs142248811	chr2:234243021-234243022	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
27	rs535714449	chr2:234243025-234243026	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
28	rs534210743	chr2:234243033-234243034	Weak transcription Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
29	rs554090067	chr2:234243048-234243049	Weak transcription Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
30	rs577122555	chr2:234243054-234243055	Weak transcription Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
31	rs543677597	chr2:234243055-234243056	Weak transcription Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
32	rs556350939	chr2:234243061-234243062	Weak transcription Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
33	rs146353781	chr2:234243124-234243125	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
34	rs116873696	chr2:234243149-234243150	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
35	rs3792094	chr2:234243150-234243151	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
36	rs560922452	chr2:234243153-234243154	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
37	rs529705374	chr2:234243186-234243187	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
38	rs7572798	chr2:234243276-234243277	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
39	rs6431310	chr2:234243322-234243323	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
40	rs62195070	chr2:234243422-234243423	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
41	rs73995906	chr2:234243438-234243439	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
42	rs534759180	chr2:234243440-234243441	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
43	rs552372662	chr2:234243449-234243450	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
44	rs117935654	chr2:234243452-234243453	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
45	rs13410746	chr2:234243457-234243458	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
46	rs2304771	chr2:234243458-234243459	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
47	rs568437536	chr2:234243472-234243473	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
48	rs371282615	chr2:234243495-234243496	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
49	rs553759359	chr2:234243504-234243505	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
50	rs570772675	chr2:234243514-234243515	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:61)

Disease	PMID	Source
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Medulloblastoma	21979893	CNVD
Ependymoma	16718352	CNVD
Melanoma	18172304	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Breast cancer	17603634	CNVD
Breast cancer	16272173	CNVD
Ewing''s sarcoma	17952124	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Liposarcoma	21253554	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Autism	16446308	CNVD
Autism	19401682	CNVD
Colorectal cancer	16272173	CNVD
Lung cancer	18438408	CNVD
Acute myeloid leukemia	20729466	CNVD
small cell lung cancer	20016488	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Urothelial carcinoma	21177765	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Cervical cancer	21062161	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Chordoma	18071362	CNVD
Developmental delay	21147756	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Cancer	22429812	CNVD
Bladder cancer	21909424	CNVD
Renal cell carcinoma	21668985	CNVD
Breast cancer	21785460	CNVD
Prostate cancer	18632612	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Wilms tumour	21544195	CNVD
Esophageal adenocarcinoma	18519675	CNVD
prenatal diagnosis	22389664	CNVD
Myelofibrosis	22110671	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Mental retardation	20152051	CNVD
Cancer	21183584	CNVD
Albright''s disease	22277900	CNVD
Brachydactyly-Mental Retardation Syndrome	22470819	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Colorectal cancer	19359472	CNVD
Autism	18414403	CNVD
Pancreatic cancer	17952125	CNVD
Congenital anomalies of the kidney and urinary tract	20605837	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:1788 , 50 per page) page: 1 2 3 4 5 6 7 ... 36

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr2:234223600-234245400	Weak transcription	Pancreas	Pancrea
2	chr2:234237200-234242800	Enhancers	Spleen	Spleen
3	chr2:234237400-234249800	Enhancers	Primary B cells from peripheral blood	blood
4	chr2:234237800-234244000	Enhancers	Primary monocytes fromperipheralblood	blood
5	chr2:234238400-234243000	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
6	chr2:234238400-234244600	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
7	chr2:234238800-234243600	Enhancers	Primary T helper naive cells fromperipheralblood	blood
8	chr2:234238800-234246600	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
9	chr2:234239200-234243000	Enhancers	Primary T regulatory cells fromperipheralblood	blood
10	chr2:234239600-234242400	Enhancers	Primary hematopoietic stem cells	blood
11	chr2:234239600-234243200	Enhancers	Primary T cells effector/memory enriched fromperipheralblood	blood
12	chr2:234239800-234243000	Enhancers	Primary mononuclear cells fromperipheralblood	Blood
13	chr2:234240200-234244000	Weak transcription	Sigmoid Colon	Sigmoid Colon
14	chr2:234240200-234244400	Weak transcription	Rectal Mucosa Donor 31	rectum
15	chr2:234240200-234245400	Weak transcription	Colonic Mucosa	Colon
16	chr2:234240400-234244600	Enhancers	Primary T cells fromperipheralblood	blood
17	chr2:234240600-234242800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
18	chr2:234240600-234244200	Enhancers	Primary T helper 17 cells PMA-I stimulated	--
19	chr2:234240600-234244800	Enhancers	Primary T helper cells fromperipheralblood	blood
20	chr2:234240800-234243200	Enhancers	Primary T killer naive cells fromperipheralblood	blood
21	chr2:234240800-234243600	Enhancers	Primary hematopoietic stem cells short term culture	blood
22	chr2:234240800-234244200	Enhancers	Primary T cells from cord blood	blood
23	chr2:234240800-234244600	Enhancers	Primary T helper memory cells from peripheral blood 2	blood
24	chr2:234240800-234244600	Enhancers	Primary T helper cells PMA-I stimulated	--
25	chr2:234240800-234244800	Enhancers	Primary T helper memory cells from peripheral blood 1	blood
26	chr2:234240800-234246600	Weak transcription	K562	blood
27	chr2:234241000-234242400	Enhancers	Fetal Muscle Leg	muscle
28	chr2:234241000-234244600	Enhancers	Primary T killer memory cells from peripheral blood	blood
29	chr2:234241000-234245400	Weak transcription	Fetal Intestine Small	intestine
30	chr2:234241000-234249600	Enhancers	Primary B cells from cord blood	blood
31	chr2:234241200-234243800	Weak transcription	GM12878-XiMat	blood
32	chr2:234241600-234242800	Enhancers	Rectal Mucosa Donor 29	rectum
33	chr2:234241800-234242600	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
34	chr2:234241800-234242600	Enhancers	Fetal Thymus	thymus
35	chr2:234241800-234243000	Enhancers	Duodenum Mucosa	Duodenum
36	chr2:234241800-234243000	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
37	chr2:234241800-234243400	Enhancers	Fetal Muscle Trunk	muscle
38	chr2:234242000-234242600	Enhancers	Placenta	Placenta
39	chr2:234242000-234243000	Flanking Active TSS	Primary neutrophils fromperipheralblood	blood
40	chr2:234242200-234242400	Flanking Active TSS	Primary T helper naive cells from peripheral blood	blood
41	chr2:234242400-234243400	Bivalent Enhancer	Fetal Muscle Leg	muscle
42	chr2:234242400-234244200	Enhancers	Primary T helper naive cells from peripheral blood	blood
43	chr2:234242600-234242800	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin01	Skin
44	chr2:234242600-234242800	Bivalent Enhancer	Placenta	Placenta
45	chr2:234242600-234243200	Bivalent Enhancer	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
46	chr2:234242800-234243600	Weak transcription	Spleen	Spleen
47	chr2:234242800-234244600	Weak transcription	Rectal Mucosa Donor 29	rectum
48	chr2:234243000-234244000	Enhancers	Primary neutrophils fromperipheralblood	blood
49	chr2:234243000-234244000	Weak transcription	Primary mononuclear cells fromperipheralblood	Blood
50	chr2:234243000-234244000	Enhancers	Monocytes-CD14+_RO01746	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links